Urothelial tumors of upper tract following treatment of primary bladder transitional cell carcinoma

Curtis B. Schwartz, Huseyin Bekirov, Arnold Melman

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

We studied, retrospectively, the incidence of upper tract urothelial tumors following the treatment of primary transitional cell carcinoma of the bladder in 638 patients. Subsequent tumor development was found in 20 patients (3.1 %) with a mean latency interval between initial treatment of the bladder cancer and diagnosis of the upper urinary tract tumor of eighty months. We did not find a significant difference among treatment modalities on the incidence of upper tract occurrences. Other than carcinoma in situ, tumor stage was not an independent predictive variable.

Original languageEnglish (US)
Pages (from-to)509-511
Number of pages3
JournalUrology
Volume40
Issue number6
DOIs
StatePublished - 1992

Fingerprint

Transitional Cell Carcinoma
Urinary Bladder
Neoplasms
Incidence
Carcinoma in Situ
Therapeutics
Urinary Tract
Urinary Bladder Neoplasms

ASJC Scopus subject areas

  • Urology

Cite this

Urothelial tumors of upper tract following treatment of primary bladder transitional cell carcinoma. / Schwartz, Curtis B.; Bekirov, Huseyin; Melman, Arnold.

In: Urology, Vol. 40, No. 6, 1992, p. 509-511.

Research output: Contribution to journalArticle

Schwartz, Curtis B. ; Bekirov, Huseyin ; Melman, Arnold. / Urothelial tumors of upper tract following treatment of primary bladder transitional cell carcinoma. In: Urology. 1992 ; Vol. 40, No. 6. pp. 509-511.
@article{dfd02152fd334b329131a89d61124622,
title = "Urothelial tumors of upper tract following treatment of primary bladder transitional cell carcinoma",
abstract = "We studied, retrospectively, the incidence of upper tract urothelial tumors following the treatment of primary transitional cell carcinoma of the bladder in 638 patients. Subsequent tumor development was found in 20 patients (3.1 {\%}) with a mean latency interval between initial treatment of the bladder cancer and diagnosis of the upper urinary tract tumor of eighty months. We did not find a significant difference among treatment modalities on the incidence of upper tract occurrences. Other than carcinoma in situ, tumor stage was not an independent predictive variable.",
author = "Schwartz, {Curtis B.} and Huseyin Bekirov and Arnold Melman",
year = "1992",
doi = "10.1016/0090-4295(92)90404-K",
language = "English (US)",
volume = "40",
pages = "509--511",
journal = "Urology",
issn = "0090-4295",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Urothelial tumors of upper tract following treatment of primary bladder transitional cell carcinoma

AU - Schwartz, Curtis B.

AU - Bekirov, Huseyin

AU - Melman, Arnold

PY - 1992

Y1 - 1992

N2 - We studied, retrospectively, the incidence of upper tract urothelial tumors following the treatment of primary transitional cell carcinoma of the bladder in 638 patients. Subsequent tumor development was found in 20 patients (3.1 %) with a mean latency interval between initial treatment of the bladder cancer and diagnosis of the upper urinary tract tumor of eighty months. We did not find a significant difference among treatment modalities on the incidence of upper tract occurrences. Other than carcinoma in situ, tumor stage was not an independent predictive variable.

AB - We studied, retrospectively, the incidence of upper tract urothelial tumors following the treatment of primary transitional cell carcinoma of the bladder in 638 patients. Subsequent tumor development was found in 20 patients (3.1 %) with a mean latency interval between initial treatment of the bladder cancer and diagnosis of the upper urinary tract tumor of eighty months. We did not find a significant difference among treatment modalities on the incidence of upper tract occurrences. Other than carcinoma in situ, tumor stage was not an independent predictive variable.

UR - http://www.scopus.com/inward/record.url?scp=0027099709&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027099709&partnerID=8YFLogxK

U2 - 10.1016/0090-4295(92)90404-K

DO - 10.1016/0090-4295(92)90404-K

M3 - Article

C2 - 1466103

AN - SCOPUS:0027099709

VL - 40

SP - 509

EP - 511

JO - Urology

JF - Urology

SN - 0090-4295

IS - 6

ER -